Terms: = Liver cancer AND CTCF, P49711, 10664, ENSG00000102974 AND Treatment
5 results:
1. Role of PDLIM1 in hepatic stellate cell activation and liver fibrosis progression.
Ye B; Yu M; Yue M; Yin M; Zhang C; Wang Q; Ding X; Shen W; Zhao Z
Sci Rep; 2023 Jul; 13(1):10946. PubMed ID: 37414929
[TBL] [Abstract] [Full Text] [Related]
2. The function of brother of the regulator of imprinted sites in cancer development.
Zhou S; Li L; Zhang M; Qin Y; Li B
Cancer Gene Ther; 2023 Feb; 30(2):236-244. PubMed ID: 36376421
[TBL] [Abstract] [Full Text] [Related]
3. ctcf and EGR1 suppress breast cancer cell migration through transcriptional control of Nm23-H1.
Wong KM; Song J; Wong YH
Sci Rep; 2021 Jan; 11(1):491. PubMed ID: 33436746
[TBL] [Abstract] [Full Text] [Related]
4. The effect of ctcf binding sites destruction by CRISPR/Cas9 on transcription of metallothionein gene family in liver hepatocellular carcinoma.
Gong W; Liu Y; Qu H; Liu A; Sun P; Wang X
Biochem Biophys Res Commun; 2019 Mar; 510(4):530-538. PubMed ID: 30738580
[TBL] [Abstract] [Full Text] [Related]
5. A ctcf-independent role for cohesin in tissue-specific transcription.
Schmidt D; Schwalie PC; Ross-Innes CS; Hurtado A; Brown GD; Carroll JS; Flicek P; Odom DT
Genome Res; 2010 May; 20(5):578-88. PubMed ID: 20219941
[TBL] [Abstract] [Full Text] [Related]
